Trial Profile
Effect of Crestor [rosuvastatin] on the kinetics of plasma apolipoproteins: dose-response study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacodynamics
- 29 Sep 2006 Status change
- 17 Dec 2005 New trial record.